Comparative analysis reveals no significant difference in clinical outcomes for otomycosis treatments using clotrimazole or natamycin.
Background: Otomycosis is a superficial fungal infection of the ear canal which requires prolonged treatment for patients and clinicians. Objectives: The aim of this study was to compare the clinical aspects of Clotrimazole 1% cream with Natamycin 5% drops in the treatment of otomycosis. Methods: This research used an unpaired numerical comparative analytic study with a parallel trial design. The study sample consisted of 30 patients with otomycosis, divided into two therapy groups; Clotrimazole cream and Natamycin drops. Clinical symptoms (pain, itching and ear fullness) and clinical signs (ear canal condition, secretions and hyphae/spores) were evaluated on days 7 and 14. Subjects were given follow-up therapy in the form of reapplication. Statistical tests were used, including the Mann-Whitney test and Fisher's Exact test. Results: No significant differences were observed in the median of otalgia, itching, and blockage score before and after treatment for Clotrimazole and Natamycin (p=0.825), (p=0.006), (p=0.016), respectively. In addition, there was a significant reduction in the number of patients reporting ear discharge (p = 0.256), secretions (p = 1.0), and hyphae/spores (p = 1.0). Conclusion: There was no significant difference in the clinical outcomes between Clotrimazole cream and Natamycin drops in patients with otomycosis.
No takes yet. Share an insight, caveat, or question.
Rahmi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: